MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$600K
Free Cash flow
$29,849K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Accounts payable, accrued expens...
Sale and redemption of marketabl...
Others
Negative Cash Flow Breakdown
Inventories
Purchases of marketable securiti...
Net loss
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
Net loss
-27,110
Amortization of debt discount and deferred financing
2,570
Depreciation and amortization
7,460
Stock-based compensation
87,410
Loss on extinguishment of debt
0
Non-cash changes in the fair value of contingent consideration payable
0
Foreign currency remeasurement loss
-3,586
Non-cash deferred taxes
0
Asset impairment charges and other write-offs
-1,138
Accounts receivable
5,860
Inventories
111,483
Prepaid expenses and other current assets
1,382
Accounts payable, accrued expenses, and other current liabilities
82,777
Other non-current assets and liabilities
-3,685
Payment of contingent consideration
0
Net cash provided by (used in) operating activities
33,145
Sale and redemption of marketable securities
51,269
Purchases of marketable securities
94,405
Capital expenditures
3,296
Net cash (used in) provided by investing activities
-46,432
Proceeds from the issuance of shares in connection with at-the-market offering, net of issuance costs
0
Proceeds from equity financing, net of issuance costs
0
Withholding taxes paid on vested restricted stock units
18,323
Proceeds from stock options exercised, net
19,205
Proceeds from warrants exercised, net
0
Payment of long-term debt
0
Proceeds from long-term debt, net of issuance costs
0
Payment of contingent consideration
0
Payment of finance leases
272
Net cash provided by financing activities
610
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
13,277
Net increase (decrease) in cash, cash equivalents, and restricted cash
600
Cash, cash equivalents, and restricted cash at the beginning of the year
216,716
Cash, cash equivalents, and restricted cash at the end of the year
217,316
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Stock-based compensation
$87,410K
Proceeds from stock
options exercised, net
$19,205K
Accounts payable,
accrued expenses, and...
$82,777K
Depreciation and
amortization
$7,460K
Foreign currency
remeasurement loss
-$3,586K
Amortization of debt discount
and deferred...
$2,570K
Net cash provided by
(used in) operating...
$33,145K
Effect of exchange rate
changes on cash, cash...
$13,277K
Net cash provided by
financing activities
$610K
Canceled cashflow
$150,658K
Canceled cashflow
$18,595K
Net increase
(decrease) in cash, cash...
$600K
Canceled cashflow
$46,432K
Inventories
$111,483K
Net loss
-$27,110K
Accounts receivable
$5,860K
Other non-current
assets and liabilities
-$3,685K
Prepaid expenses and
other current assets
$1,382K
Asset impairment
charges and other...
-$1,138K
Sale and redemption
of marketable...
$51,269K
Withholding taxes paid on
vested restricted...
$18,323K
Payment of finance
leases
$272K
Net cash (used in)
provided by investing...
-$46,432K
Canceled cashflow
$51,269K
Purchases of marketable
securities
$94,405K
Capital expenditures
$3,296K
Buy us a coffee
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)